Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
Werewolf Therapeutics (HOWL) Stock Price & Analysis
138 Followers
HOWL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.57 - $8.19
Previous Close$5.48
Volume126.57K
Average Volume (3M)190.22K
Market Cap
$238.14M
Enterprise Value$160.27M
Total Cash (Recent Filing)$130.06M
Total Debt (Recent Filing)$52.19M
Price to Earnings (P/E)-5.0
Beta0.92
Next Earnings
Aug 08, 2024EPS Estimate
-$0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.09
Shares Outstanding43,455,367
10 Day Avg. Volume124,893
30 Day Avg. Volume190,221
Standard Deviation0.27
R-Squared0.02
Alpha-0.00055
Financial Highlights & Ratios
Price to Book (P/B)2.21
Price to Sales (P/S)285.53
Price to Cash Flow (P/CF)-8.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue24.11
Enterprise Value/Gross Profit192.16
Enterprise Value/Ebitda-4.93
Forecast
1Y Price Target
$12.00Price Target Upside115.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Werewolf Therapeutics News
Ownership Overview
77.04%
Insiders
2.69% Mutual Funds
2.83% Other Institutional Investors
17.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
HOWL FAQ
What was Werewolf Therapeutics’s price range in the past 12 months?
Werewolf Therapeutics lowest stock price was $1.57 and its highest was $8.19 in the past 12 months.
What is Werewolf Therapeutics’s market cap?
Currently, no data Available
When is Werewolf Therapeutics’s upcoming earnings report date?
Werewolf Therapeutics’s upcoming earnings report date is Aug 08, 2024 which is in 90 days.
How were Werewolf Therapeutics’s earnings last quarter?
Werewolf Therapeutics released its earnings results on May 03, 2024. The company reported -$0.39 earnings per share for the quarter, missing the consensus estimate of -$0.342 by -$0.048.
Is Werewolf Therapeutics overvalued?
According to Wall Street analysts Werewolf Therapeutics’s price is currently Undervalued.
Does Werewolf Therapeutics pay dividends?
Werewolf Therapeutics does not currently pay dividends.
What is Werewolf Therapeutics’s EPS estimate?
Werewolf Therapeutics’s EPS estimate is -$0.36.
How many shares outstanding does Werewolf Therapeutics have?
Werewolf Therapeutics has 43,455,368 shares outstanding.
What happened to Werewolf Therapeutics’s price movement after its last earnings report?
Werewolf Therapeutics reported an EPS of -$0.39 in its last earnings report, missing expectations of -$0.342. Following the earnings report the stock price went down -0.164%.
Which hedge fund is a major shareholder of Werewolf Therapeutics?
Among the largest hedge funds holding Werewolf Therapeutics’s share is RA Capital Management. It holds Werewolf Therapeutics’s shares valued at 24M.
---
Werewolf Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.00 (115.44% Upside)
$12.00 (115.44% Upside)
Blogger Sentiment
Bullish
HOWL Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Positive
Last 7 Days <0.1%
Last 30 Days ▲ 10.7%
Last 30 Days ▲ 10.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
87.03%
12-Months-Change
Fundamentals
Return on Equity
-34.84%
Trailing 12-Months
Asset Growth
-8.96%
Trailing 12-Months
Company Description
Werewolf Therapeutics
Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
---
HOWL Stock 12 Month Forecast
Average Price Target
$12.00
▲(115.44% Upside)
Technical Analysis
Best Analysts Covering HOWL
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+61.63%
reiterated a buy rating 21 days ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +61.63% per trade.
---